Mediclinic International PLC
LSE:MDC
Mediclinic International PLC
LSE:MDC
Price:
501 GBX
Updated:
May 15, 2024
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA
22.7
Current
22.6
Median
12.9
Industry
Higher
than median
Higher
than industry value
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
EV/EBITDA
=22.7
Enterprise Value
/
5.8B
EBITDA
254m
All Countries
| Market Cap | EV/EBITDA | ||||
|---|---|---|---|---|---|
| UK |
|
Mediclinic International PLC
LSE:MDC
|
3.7B GBP | 22.7 | |
| US |
|
HCA Healthcare Inc
NYSE:HCA
|
84.8B USD | 9.4 | |
| SA |
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
103B SAR | 43.2 | |
| CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
118.7B CNY | 23.5 | |
| ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
15.6B Zac | 0 | |
| ZA |
N
|
Netcare Ltd
JSE:NTC
|
15.1B Zac | 0 | |
| BR |
|
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
69.2B BRL | 10.2 | |
| TH |
B
|
Bangkok Dusit Medical Services PCL
SET:BDMS
|
464.8B THB | 19 | |
| US |
|
Tenet Healthcare Corp
NYSE:THC
|
12.6B USD | 6 | |
| US |
|
Universal Health Services Inc
NYSE:UHS
|
12B USD | 9 | |
| MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
54.9B MYR | 10.6 |
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBITDA
9.6
2-Years Forward
EV/EBITDA
9.1
3-Years Forward
EV/EBITDA
8.7
You don't have any saved screeners yet
